Kojic amine
Kojic amine is an orally active γ-aminobutyric acid (GABA) analog. Kojic amine acts as a GABA mimic that inhibits sodium-independent [3H]GABA binding to rat brain cell membranes. Kojic amine reduces flexor spasms in chronic spinal rat and cat models. Kojic amine prevents tonic extensor convulsions in mice. Kojic amine produces a transient, dose-dependent analgesic effect in the mouse hot-plate test. Kojic amine can be used in research related to skeletal muscle spasm, epilepsy and analgesia[1][2]
For research use only. We do not sell to patients.
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
Kojic amine (Compound 3) potently and specifically inhibits the Na+-independent binding of [3H]GABA to rat brain cell membranes[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Kojic amine (i.v., oral administration; cumulative dosing) reduces flexor reflex spasm in chronic spinal cats by 70%, with an intravenous ED70 of 2.2 mg/kg and an oral ED70 of 4 mg/kg[1].
Kojic amine (15-128 mg/kg; i.g.; single dose) prevents 3-mercaptopropionic acid-induced tonic extensor convulsions in 50% of mice at an oral ED50 of 15 mg/kg[1].
Kojic amine (8.2-15.7 mg/kg; i.p.; single administration) produces dose-dependent, short-acting analgesic effects in the mouse hot-plate test at 48°C and 55°C, with ED50 values of 9.2 mg/kg and 13.8 mg/kg, respectively[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Robidoux Swiss (male, 18-22 g, 3-mercaptopropionic acid-induced convulsions)[1]
-
Dosage:15 mg/kg (seizure prevention ED50); 128 mg/kg (acute oral non-lethal)
-
Administration:p.o.; single dose (30 mins prior to convulsion induction)
-
Result:Prevented tonic extensor seizures in 50% of mice (ED50) challenged with 3-mercaptopropionic acid.
Allowed all mice to survive an acute oral dose of 128 mg/kg.
-
Animal Model:albino Swiss CD-1 (male, 18-24 g)[2]
-
Dosage:8.2-15.7 mg/kg
-
Administration:i.p.; single dose
-
Result:Produced dose-dependent, short-acting analgesic effects in the mouse hot-plate test at 48°C and 55°C, with ED50 values of 9.2 mg/kg and 13.8 mg/kg, respectively.
Chemical Information
-
CAS No. 68642-64-8
-
Molecular Weight 141.13
-
Formula C6H7NO3
-
SMILES
O=C1C=C(OC=C1O)CN
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Kojic amine Related Classifications
HY-121554 Related Classifications
Powered by Bioz